CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 129 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $179,000 | -45.3% | 67,211 | -11.0% | 0.00% | -50.0% |
| Q4 2021 | $327,000 | -19.5% | 75,513 | -5.4% | 0.00% | 0.0% |
| Q3 2021 | $406,000 | -25.1% | 79,853 | -6.7% | 0.00% | -20.0% |
| Q2 2021 | $542,000 | -16.1% | 85,629 | +2.4% | 0.01% | -16.7% |
| Q1 2021 | $646,000 | +18.1% | 83,629 | +0.2% | 0.01% | 0.0% |
| Q4 2020 | $547,000 | -13.7% | 83,493 | +1.1% | 0.01% | -40.0% |
| Q1 2020 | $634,000 | -17.2% | 82,601 | -10.4% | 0.01% | +66.7% |
| Q4 2019 | $766,000 | – | 92,233 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 524,763 | $7,924,000 | 3.84% |
| Congress Park Capital LLC | 123,311 | $1,862,000 | 2.05% |
| Perceptive Advisors | 2,911,715 | $43,588,000 | 1.66% |
| RTW INVESTMENTS, LP | 908,586 | $13,720,000 | 1.28% |
| HAMILTON LANE ADVISORS LLC | 68,753 | $1,038,000 | 0.91% |
| HARBOURVEST PARTNERS LLC | 79,193 | $1,196,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 273,151 | $4,125,000 | 0.46% |
| Exane Asset Management | 50,000 | $755,000,000 | 0.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 622,548 | $9,400,000 | 0.38% |
| Cormorant Asset Management, LP | 296,712 | $4,480,000 | 0.36% |